Prevention

The CDC’s Advisory Committee on Immunization Practices has included HEPLISAV-B on its list of recommended products for use to vaccinate adults against hepatitis B.

One agency estimates that at least 50% of all antibiotic prescriptions written in the United States do not fall under currently accepted practice guidelines.

Barley Chironda, RPN, CIC, discusses different high-touch surfaces in hospital rooms that are known to harbor pathogenic bacteria.

A molecule capable of clearing HSV-1 infection in the cells of the cornea could be a promising potential option for those who have developed resistance to current drugs.

Massive vaccination campaigns launched in Brazil and Nigeria strive to quell ongoing outbreaks.

Marin H. Kollef, MD, discusses treatment options for Pseudomonas aeruginosa.

Can culturing process changes reduce the impact of catheter-associated urinary tract infections (CAUTIs)?

In case you missed them, we’ve compiled a list of the latest recalls posted this week.

Glenn Tillotson, PhD, FIDSA, provides insight into the growing problem and cost of antimicrobial resistance.

Providing investments in 10 vaccines during a 15-year period in low- and middle-income nations could prevent 36 million deaths and 24 million cases of poverty related to medical reasons.

A panel of experts from the Philippines Department of Health finds that Sanofi Pasteur's dengue fever vaccine, Dengvaxia (CYD-TDV), may be connected with 3 deaths.

Bacteriophages are emerging as an alternative to treat highly resistant infections.

Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.

Infectious disease specialists and public health professionals in search of a to-do list for 2018 need look no further.

Efforts to curb antimicrobial resistance have hit a brick wall in India, where new research finds unapproved drug combinations are rampant.

An international research team finds that targeting the social and risk networks of patients recently diagnosed with HIV is leading them to more patients unknowingly infected with the virus.

Was the situation in Flint, Michigan an outlier or an ominous warning of what’s to come?

Dr. Richard Vickers, discusses what the next steps are for Summit Therapeutic’s ridinilazole.

A Nebraska mother’s Facebook post has parents and health experts around the country wondering if an influenza B infection may have caused hives in a child who did not present with any other flu symptoms.

Marin H. Kollef, MD, discusses what to consider when calling for cultures.

In case you missed them, we've compiled the top five infectious disease articles from this past week.

The CDC’s acting director provides a somber flu update and stresses the need to stay vigilant against the virus.